Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rasmussen, TN; Schmidt, P; Poulsen, SS; Holst, JJ
   Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum
   NEUROGASTROENTEROLOGY AND MOTILITY
   
   T.N. Rasmussen et al., "Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum", NEUROG MOT, 13(4), 2001, pp. 353-359
2. Verdich, C; Toubro, S; Buemann, B; Holst, JJ; Bulow, J; Simonsen, L; Sondergaard, SB; Christensen, NJ; Astrup, A
   Leptin levels are associated with fat oxidation and dietary-induced weightloss in obesity
   OBESITY RESEARCH
   
   C. Verdich et al., "Leptin levels are associated with fat oxidation and dietary-induced weightloss in obesity", OBES RES, 9(8), 2001, pp. 452-461
3. Ronnblom, A; Hellstrom, PM; Holst, JJ; Theodorsson, E; Danielsson, A
   Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy
   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
   
   A. Ronnblom et al., "Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy", EUR J GASTR, 13(7), 2001, pp. 825-831
4. Gutniak, MK; Svartberg, J; Hellstrom, PM; Holst, JJ; Adner, N; Ahren, B
   Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes
   JOURNAL OF INTERNAL MEDICINE
   
   M.K. Gutniak et al., "Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes", J INTERN M, 250(1), 2001, pp. 81-87
5. Vilsboll, T; Krarup, T; Madsbad, S; Holst, JJ
   No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose
   DIABETIC MEDICINE
   
   T. Vilsboll et al., "No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose", DIABET MED, 18(2), 2001, pp. 144-149
6. Knudsen, LB; Agerso, H; Bjenning, C; Bregenholt, S; Carr, RD; Godtfredsen, C; Holst, JJ; Huusfeldt, PO; Larsen, MO; Larsen, PJ; Nielsen, PF; Ribel, U; Rolin, B; Romer, J; Sturis, J; Wilken, M; Kristensen, P
   GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development
   DRUGS OF THE FUTURE
   
   L.B. Knudsen et al., "GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development", DRUG FUTURE, 26(7), 2001, pp. 677-685
7. Verdich, C; Toubro, S; Buemann, B; Madsen, JL; Holst, JJ; Astrup, A
   The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction
   INTERNATIONAL JOURNAL OF OBESITY
   
   C. Verdich et al., "The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction", INT J OBES, 25(8), 2001, pp. 1206-1214
8. Flint, A; Raben, A; Ersboll, AK; Holst, JJ; Astrup, A
   The effect of physiological levels of glucagon-like peptide-1 on appetite,gastric emptying, energy and substrate metabolism in obesity
   INTERNATIONAL JOURNAL OF OBESITY
   
   A. Flint et al., "The effect of physiological levels of glucagon-like peptide-1 on appetite,gastric emptying, energy and substrate metabolism in obesity", INT J OBES, 25(6), 2001, pp. 781-792
9. Enc, FY; Imeryuz, N; Akin, L; Turoglu, T; Dede, F; Haklar, G; Tekesin, N; Bekiroglu, N; Yegen, BC; Rehfeld, JF; Holst, JJ; Ulusoy, NB
   Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release
   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
   
   F.Y. Enc et al., "Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release", AM J P-GAST, 281(3), 2001, pp. G752-G763
10. Ljungmann, K; Hartmann, B; Kissmeyer-Nielsen, P; Flyvbjerg, A; Holst, JJ; Laurberg, S
    Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    
    K. Ljungmann et al., "Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats", AM J P-GAST, 281(3), 2001, pp. G779-G785
11. Hojlund, K; Wildner-Christensen, M; Eshoj, O; Skjaerbaek, C; Holst, JJ; Koldkjaer, O; Jensen, DM; Beck-Nielsen, H
    Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    K. Hojlund et al., "Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting", AM J P-ENDO, 280(1), 2001, pp. E50-E58
12. Rasmussen, TN; Schmidt, P; Poulsen, SS; Holst, JJ
    Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum
    REGULATORY PEPTIDES
    
    T.N. Rasmussen et al., "Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum", REGUL PEPT, 98(3), 2001, pp. 137-143
13. Tornoe, K; Hannibal, J; Georg, B; Schmidt, PT; Hilsted, L; Fahrenkrug, J; Holst, JJ
    PACAP 1-38 as neurotransmitter in the porcine antrum
    REGULATORY PEPTIDES
    
    K. Tornoe et al., "PACAP 1-38 as neurotransmitter in the porcine antrum", REGUL PEPT, 101(1-3), 2001, pp. 109-121
14. Gebhard, B; Holst, JJ; Biegelmayer, C; Miholic, J
    Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome
    DIGESTIVE DISEASES AND SCIENCES
    
    B. Gebhard et al., "Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome", DIG DIS SCI, 46(9), 2001, pp. 1915-1923
15. Thulesen, J; Hartman, B; Kissow, H; Jeppsen, PK; Orskov, C; Holst, JJ; Poulsen, SS
    Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection
    DIGESTIVE DISEASES AND SCIENCES
    
    J. Thulesen et al., "Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection", DIG DIS SCI, 46(2), 2001, pp. 379-388
16. Rask, E; Olsson, T; Soderberg, S; Johnson, O; Seckl, J; Holst, JJ; Ahren, B
    Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men
    DIABETES CARE
    
    E. Rask et al., "Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men", DIABET CARE, 24(9), 2001, pp. 1640-1645
17. Zander, M; Taskiran, M; Toft-Nielsen, MB; Madsbad, S; Holst, JJ
    Additive glucose-lowering effects of glucagon-like peptide-1 and metforminin type 2 diabetes
    DIABETES CARE
    
    M. Zander et al., "Additive glucose-lowering effects of glucagon-like peptide-1 and metforminin type 2 diabetes", DIABET CARE, 24(4), 2001, pp. 720-725
18. Naslund, E; Bogefors, J; Gryback, P; Bjellerup, P; Jacobsson, H; Holst, JJ; Hellstrom, PM
    GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium, or osmolality
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    E. Naslund et al., "GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium, or osmolality", SC J GASTR, 36(2), 2001, pp. 156-162
19. Holst, JJ; Orskov, C
    Incretin hormones - an update
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    
    J.J. Holst e C. Orskov, "Incretin hormones - an update", SC J CL INV, 61, 2001, pp. 75-85
20. van Goudoever, JB; Stoll, B; Hartmann, B; Holst, JJ; Reeds, PJ; Burrin, DG
    Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets
    JOURNAL OF NUTRITION
    
    J.B. van Goudoever et al., "Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets", J NUTR, 131(3), 2001, pp. 729-732
21. Friis-Hansen, L; Lacourse, KA; Samuelson, LC; Holst, JJ
    Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice
    JOURNAL OF ENDOCRINOLOGY
    
    L. Friis-Hansen et al., "Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice", J ENDOCR, 169(3), 2001, pp. 595-602
22. Verdich, C; Flint, A; Gutzwiller, JP; Naslund, E; Beglinger, C; Hellstrom, PM; Long, SJ; Morgan, LM; Holst, JJ; Astrup, A
    A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    C. Verdich et al., "A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans", J CLIN END, 86(9), 2001, pp. 4382-4389
23. Toft-Nielsen, MB; Damholt, MB; Madsbad, S; Hilsted, LM; Hughes, TE; Michelsen, BK; Holst, JJ
    Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    M.B. Toft-Nielsen et al., "Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients", J CLIN END, 86(8), 2001, pp. 3717-3723
24. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
    Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    M.B. Toft-Nielsen et al., "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes", J CLIN END, 86(8), 2001, pp. 3853-3860
25. Jeppesen, PB; Hartmann, B; Thulesen, J; Graff, J; Lohmann, J; Hansen, BS; Tofteng, F; Poulsen, SS; Madsen, JL; Holst, JJ; Mortensen, PB
    Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon
    GASTROENTEROLOGY
    
    P.B. Jeppesen et al., "Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon", GASTROENTY, 120(4), 2001, pp. 806-815
26. Deacon, CF; Danielson, P; Klarskov, L; Olesen, M; Holst, JJ
    Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs
    DIABETES
    
    C.F. Deacon et al., "Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs", DIABETES, 50(7), 2001, pp. 1588-1597
27. Staehr, P; Hother-Nielsen, O; Levin, K; Holst, JJ; Beck-Nielsen, H
    Assessment of hepatic insulin action in obese type 2 diabetic patients
    DIABETES
    
    P. Staehr et al., "Assessment of hepatic insulin action in obese type 2 diabetic patients", DIABETES, 50(6), 2001, pp. 1363-1370
28. Ahren, B; Holst, JJ
    The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia
    DIABETES
    
    B. Ahren e J.J. Holst, "The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia", DIABETES, 50(5), 2001, pp. 1030-1038
29. Ritzel, R; Schulte, M; Porksen, N; Nauck, MS; Holst, JJ; Juhl, C; Marz, W; Schmitz, O; Schmiegel, WH; Nauck, MA
    Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance
    DIABETES
    
    R. Ritzel et al., "Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance", DIABETES, 50(4), 2001, pp. 776-784
30. Vella, A; Shah, P; Basu, R; Basu, A; Camilleri, M; Schwenk, FW; Holst, JJ; Rizza, RA
    Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes
    DIABETES
    
    A. Vella et al., "Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes", DIABETES, 50(3), 2001, pp. 565-572
31. Vilsboll, T; Krarup, T; Deacon, CF; Madsbad, S; Holst, JJ
    Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
    DIABETES
    
    T. Vilsboll et al., "Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients", DIABETES, 50(3), 2001, pp. 609-613
32. Meier, JJ; Huking, K; Holst, JJ; Deacon, CF; Schmiegel, WH; Nauck, MA
    Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes
    DIABETES
    
    J.J. Meier et al., "Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes", DIABETES, 50(11), 2001, pp. 2497-2504
33. Raben, A; Holst, JJ; Madsen, J; Astrup, A
    Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal weight never-obese and postobese women
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    A. Raben et al., "Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal weight never-obese and postobese women", AM J CLIN N, 73(2), 2001, pp. 177-189
34. Schmidt, PT; Holst, JJ
    Tachykinins in regulation of gastric motility and secretion
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    P.T. Schmidt e J.J. Holst, "Tachykinins in regulation of gastric motility and secretion", CELL MOL L, 57(4), 2000, pp. 579-588
35. Schmidt, PT; Tornoe, K; Poulsen, SS; Rasmussen, TN; Holst, JJ
    Tachykinins in the porcine pancreas: Potent exocrine and endocrine effectsvia NK-1 receptors
    PANCREAS
    
    P.T. Schmidt et al., "Tachykinins in the porcine pancreas: Potent exocrine and endocrine effectsvia NK-1 receptors", PANCREAS, 20(3), 2000, pp. 241-247
36. Hedetoft, C; Sheikh, SP; Larsen, S; Holst, JJ
    Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis
    PANCREAS
    
    C. Hedetoft et al., "Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis", PANCREAS, 20(1), 2000, pp. 25-31
37. Jorgensen, TOL; Rosenfalck, AM; Fisker, S; Nyholm, B; Fineman, MS; Schmitz, O; Madsbad, S; Holst, JJ; Christiansen, JS
    Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study
    EUROPEAN JOURNAL OF ENDOCRINOLOGY
    
    T.O.L. Jorgensen et al., "Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study", EUR J ENDOC, 143(5), 2000, pp. 593-599
38. Juntti-Berggren, L; Pigon, J; Hellstrom, P; Holst, JJ; Efendic, S
    Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes
    DIABETES NUTRITION & METABOLISM
    
    L. Juntti-Berggren et al., "Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes", DIABET NUTR, 13(1), 2000, pp. 7-12
39. Filipsson, K; Holst, JJ; Ahren, B
    PACAP contributes to insulin secretion after gastric glucose gavage in mice
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    
    K. Filipsson et al., "PACAP contributes to insulin secretion after gastric glucose gavage in mice", AM J P-REG, 279(2), 2000, pp. R424-R432
40. Verdich, C; Madsen, JL; Toubro, S; Buemann, B; Holst, JJ; Astrup, A
    Effect of obesity and major weight reduction on gastric emptying
    INTERNATIONAL JOURNAL OF OBESITY
    
    C. Verdich et al., "Effect of obesity and major weight reduction on gastric emptying", INT J OBES, 24(7), 2000, pp. 899-905
41. Flint, A; Raben, A; Rehfeld, JF; Holst, JJ; Astrup, A
    The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
    INTERNATIONAL JOURNAL OF OBESITY
    
    A. Flint et al., "The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans", INT J OBES, 24(3), 2000, pp. 288-298
42. Thulesen, J; Hartmann, B; Orskov, C; Jeppesen, PB; Holst, JJ; Poulsen, SS
    Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected I-125-GLP-2
    PEPTIDES
    
    J. Thulesen et al., "Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected I-125-GLP-2", PEPTIDES, 21(10), 2000, pp. 1511-1517
43. Hartmann, B; Johnsen, AH; Orskov, C; Adelhorst, K; Thim, L; Holst, JJ
    Structure, measurement, and secretion of human glucagon-like peptide-2
    PEPTIDES
    
    B. Hartmann et al., "Structure, measurement, and secretion of human glucagon-like peptide-2", PEPTIDES, 21(1), 2000, pp. 73-80
44. Burrin, DG; Stoll, B; Jiang, R; Petersen, Y; Elnif, J; Buddington, RK; Schmidt, M; Holst, JJ; Hartmann, B; Sangild, PT
    GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    
    D.G. Burrin et al., "GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis", AM J P-GAST, 279(6), 2000, pp. G1249-G1256
45. Tornoe, K; Hannibal, J; Jensen, TB; Georg, B; Rickelt, LF; Andreasen, MB; Fahrenkrug, J; Holst, JJ
    PACAP-(1-38) as neurotransmitter in the porcine adrenal glands
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    K. Tornoe et al., "PACAP-(1-38) as neurotransmitter in the porcine adrenal glands", AM J P-ENDO, 279(6), 2000, pp. E1413-E1425
46. Hansen, L; Hartmann, B; Bisgaard, T; Mineo, H; Jorgensen, PN; Holst, JJ
    Somatostatin restrains the secretion of glucagon-like peptide-1 and-2 fromisolated perfused porcine ileum
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    L. Hansen et al., "Somatostatin restrains the secretion of glucagon-like peptide-1 and-2 fromisolated perfused porcine ileum", AM J P-ENDO, 278(6), 2000, pp. E1010-E1018
47. Holst, JJ
    Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2
    REGULATORY PEPTIDES
    
    J.J. Holst, "Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2", REGUL PEPT, 93(1-3), 2000, pp. 45-51
48. Vilsboll, T; Toft-Nielsen, MB; Krarup, T; Madsbad, S; Dinesen, B; Holst, JJ
    Evaluation of beta-cell secretory capacity using glucagon-like peptide 1
    DIABETES CARE
    
    T. Vilsboll et al., "Evaluation of beta-cell secretory capacity using glucagon-like peptide 1", DIABET CARE, 23(6), 2000, pp. 807-812
49. Henriksen, JH; Holst, JJ; Moller, S; Andersen, UB; Bendtsen, F; Jensen, G
    Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin
    CLINICAL SCIENCE
    
    J.H. Henriksen et al., "Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin", CLIN SCI, 99(6), 2000, pp. 527-534
50. Schmidt, PT; Hartmann, B; Bregenholt, S; Holst, JJ; Claesson, MH
    Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+T cells
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    P.T. Schmidt et al., "Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+T cells", SC J GASTR, 35(5), 2000, pp. 522-527
51. Buemann, B; Toubro, S; Holst, JJ; Rehfeld, JF; Bibby, BM; Astrup, A
    D-tagatose, a stereoisomer of d-fructose, increases blood uric acid concentration
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    B. Buemann et al., "D-tagatose, a stereoisomer of d-fructose, increases blood uric acid concentration", METABOLISM, 49(8), 2000, pp. 969-976
52. Poulsen, PL; Orskov, L; Grofte, T; Moller, J; Holst, JJ; Schmitz, O; Moller, N
    Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    P.L. Poulsen et al., "Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man", METABOLISM, 49(12), 2000, pp. 1598-1603
53. Hartmann, B; Harr, MB; Jeppesen, PB; Wojdemann, M; Deacon, CF; Mortensen, PB; Holst, JJ
    In vivo and in vitro degradation of glucagon-like peptide-2 in humans
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    B. Hartmann et al., "In vivo and in vitro degradation of glucagon-like peptide-2 in humans", J CLIN END, 85(8), 2000, pp. 2884-2888
54. Ahren, B; Holst, JJ; Efendic, S
    Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    B. Ahren et al., "Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes", J CLIN END, 85(3), 2000, pp. 1043-1048
55. Deacon, CF; Nauck, MA; Meier, J; Hucking, K; Holst, JJ
    Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    C.F. Deacon et al., "Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide", J CLIN END, 85(10), 2000, pp. 3575-3581
56. Jeppesen, PB; Hartmann, B; Thulesen, J; Hansen, BS; Holst, JJ; Poulsen, SS; Mortensen, PB
    Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon
    GUT
    
    P.B. Jeppesen et al., "Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon", GUT, 47(3), 2000, pp. 370-376
57. Ahren, B; Holst, JJ; Martensson, H; Balkan, B
    Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    B. Ahren et al., "Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice", EUR J PHARM, 404(1-2), 2000, pp. 239-245
58. Ahren, B; Holst, JJ; Yu, SK
    1,5-anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    B. Ahren et al., "1,5-anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice", EUR J PHARM, 397(1), 2000, pp. 219-225
59. Hartmann, B; Thulesen, J; Kissow, H; Thulesen, S; Orskov, C; Ropke, C; Poulsen, SS; Holst, JJ
    Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect ofglucagon-like peptide-2 rats and mice
    ENDOCRINOLOGY
    
    B. Hartmann et al., "Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect ofglucagon-like peptide-2 rats and mice", ENDOCRINOL, 141(11), 2000, pp. 4013-4020
60. Juhl, CB; Schmitz, O; Pincus, S; Holst, JJ; Veldhuis, J; Porksen, N
    Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness
    DIABETOLOGIA
    
    C.B. Juhl et al., "Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness", DIABETOLOG, 43(5), 2000, pp. 583-588
61. Henriksen, JE; Levin, K; Thye-Ronn, P; Alford, F; Hother-Nielsen, O; Holst, JJ; Beck-Nielsen, H
    Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients
    DIABETES
    
    J.E. Henriksen et al., "Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients", DIABETES, 49(7), 2000, pp. 1209-1218
62. Vella, A; Shah, P; Basu, R; Basu, A; Holst, JJ; Rizza, RA
    Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness andinsulin action in people with type 2 diabetes
    DIABETES
    
    A. Vella et al., "Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness andinsulin action in people with type 2 diabetes", DIABETES, 49(4), 2000, pp. 611-617
63. Burrin, DG; Stoll, B; Jiang, RH; Chang, XY; Hartmann, B; Holst, JJ; Greeley, GH; Reeds, PJ
    Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    D.G. Burrin et al., "Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?", AM J CLIN N, 71(6), 2000, pp. 1603-1610
64. Madsen, P; Brand, CL; Holst, JJ; Knudsen, LB
    Advances in non-peptide glucagon receptor antagonists
    CURRENT PHARMACEUTICAL DESIGN
    
    P. Madsen et al., "Advances in non-peptide glucagon receptor antagonists", CUR PHARM D, 5(9), 1999, pp. 683-691
65. Holst, JJ
    Glucagon-like peptide 1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential
    TRENDS IN ENDOCRINOLOGY AND METABOLISM
    
    J.J. Holst, "Glucagon-like peptide 1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential", TRENDS ENDO, 10(6), 1999, pp. 229-235
66. Tang-Christensen, M; Holst, JJ; Hartmann, B; Vrang, N
    The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin
    NEUROREPORT
    
    M. Tang-Christensen et al., "The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin", NEUROREPORT, 10(6), 1999, pp. 1183-1187
67. Holst, JJ
    Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential
    CURRENT MEDICINAL CHEMISTRY
    
    J.J. Holst, "Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential", CURR MED CH, 6(11), 1999, pp. 1005-1017
68. Plockinger, U; Holst, JJ; Messerschmidt, D; Hopfenmuller, W; Quabbe, HJ
    Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects
    EUROPEAN JOURNAL OF ENDOCRINOLOGY
    
    U. Plockinger et al., "Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects", EUR J ENDOC, 140(6), 1999, pp. 538-544
69. Naslund, E; Bogefors, J; Skogar, S; Gryback, P; Jacobsson, H; Holst, JJ; Hellstrom, PM
    GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYYrelease in humans
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    
    E. Naslund et al., "GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYYrelease in humans", AM J P-REG, 46(3), 1999, pp. R910-R916
70. Naslund, E; Barkeling, B; King, N; Gutniak, M; Blundell, JE; Holst, JJ; Rossner, S; Hellstrom, PM
    Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
    INTERNATIONAL JOURNAL OF OBESITY
    
    E. Naslund et al., "Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.", INT J OBES, 23(3), 1999, pp. 304-311
71. Klausen, B; Toubro, S; Ranneries, C; Rehfeld, JF; Holst, JJ; Christensen, NJ; Astrup, A
    Increased intensity of a single exercise bout stimulates subsequent fat intake
    INTERNATIONAL JOURNAL OF OBESITY
    
    B. Klausen et al., "Increased intensity of a single exercise bout stimulates subsequent fat intake", INT J OBES, 23(12), 1999, pp. 1282-1287
72. Henriksen, JH; Holst, JJ; Moller, S; Brinch, K; Bendtsen, F
    Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal
    HEPATOLOGY
    
    J.H. Henriksen et al., "Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal", HEPATOLOGY, 29(6), 1999, pp. 1818-1824
73. Wojdemann, M; Riber, C; Bisgaard, T; Sternby, B; Larsen, S; Rehfeld, JF; Holst, JJ; Olsen, O
    Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin
    REGULATORY PEPTIDES
    
    M. Wojdemann et al., "Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin", REGUL PEPT, 80(3), 1999, pp. 101-106
74. Olesen, M; Gudmand-Hoyer, E; Holst, JJ; Jorgensen, S
    Importance of colonic bacterial fermentation in short bowel patients - Small intestinal malabsorption of easily digestible carbohydrate
    DIGESTIVE DISEASES AND SCIENCES
    
    M. Olesen et al., "Importance of colonic bacterial fermentation in short bowel patients - Small intestinal malabsorption of easily digestible carbohydrate", DIG DIS SCI, 44(9), 1999, pp. 1914-1923
75. Schmidt, PT; Rickelt, LF; Holst, JJ
    Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors
    DIGESTIVE DISEASES AND SCIENCES
    
    P.T. Schmidt et al., "Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors", DIG DIS SCI, 44(7), 1999, pp. 1273-1281
76. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
    Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients
    DIABETES CARE
    
    M.B. Toft-Nielsen et al., "Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients", DIABET CARE, 22(7), 1999, pp. 1137-1143
77. Deacon, CF; Holst, JJ; Carr, RD
    Glucagon-like peptide-1: A basis for new approaches to the management of diabetes
    DRUGS OF TODAY
    
    C.F. Deacon et al., "Glucagon-like peptide-1: A basis for new approaches to the management of diabetes", DRUGS TODAY, 35(3), 1999, pp. 159-170
78. Wojdemann, M; Wettergren, A; Hartmann, B; Hilsted, L; Holst, JJ
    Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    M. Wojdemann et al., "Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2", J CLIN END, 84(7), 1999, pp. 2513-2517
79. Thulesen, J; Hartmann, B; Nielsen, C; Holst, JJ; Poulsen, SS
    Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre
    GUT
    
    J. Thulesen et al., "Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre", GUT, 45(5), 1999, pp. 672-678
80. Schmidt, PT; Eriksen, L; Loftager, M; Rasmussen, TN; Holst, JJ
    Fast acting nervous regulation of immunoglobulin A secretion from isolatedperfused porcine ileum
    GUT
    
    P.T. Schmidt et al., "Fast acting nervous regulation of immunoglobulin A secretion from isolatedperfused porcine ileum", GUT, 45(5), 1999, pp. 679-685
81. Jeppesen, PB; Hartmann, B; Hansen, BS; Thulesen, J; Holst, JJ; Mortensen, PB
    Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure
    GUT
    
    P.B. Jeppesen et al., "Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure", GUT, 45(4), 1999, pp. 559-563
82. Jensen, PB; Kristensen, P; Clausen, JT; Judge, ME; Hastrup, S; Thim, L; Wulff, BS; Foged, C; Jensen, J; Holst, JJ; Madsen, OD
    The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans
    FEBS LETTERS
    
    P.B. Jensen et al., "The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans", FEBS LETTER, 447(2-3), 1999, pp. 139-143
83. Bokvist, K; Hoy, M; Buschard, K; Holst, JJ; Thomsen, MK; Gromada, J
    Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    K. Bokvist et al., "Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells", EUR J PHARM, 386(1), 1999, pp. 105-111
84. Hansen, L; Deacon, CF; Orskov, C; Holst, JJ
    Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine
    ENDOCRINOLOGY
    
    L. Hansen et al., "Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine", ENDOCRINOL, 140(11), 1999, pp. 5356-5363
85. Damholt, AB; Buchan, AMJ; Holst, JJ; Kofod, H
    Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2
    ENDOCRINOLOGY
    
    A.B. Damholt et al., "Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2", ENDOCRINOL, 140(10), 1999, pp. 4800-4808
86. Nyholm, B; Walker, M; Gravholt, CH; Shearing, PA; Sturis, J; Alberti, KGMM; Holst, JJ; Schmitz, O
    Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations
    DIABETOLOGIA
    
    B. Nyholm et al., "Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations", DIABETOLOG, 42(11), 1999, pp. 1314-1323
87. Balkan, B; Kwasnik, L; Miserendino, R; Holst, JJ; Li, X
    Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obeseZucker rats
    DIABETOLOGIA
    
    B. Balkan et al., "Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obeseZucker rats", DIABETOLOG, 42(11), 1999, pp. 1324-1331
88. Thomsen, C; Rasmussen, O; Lousen, T; Holst, JJ; Fenselau, S; Schrezenmeir, J; Hermansen, K
    Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    C. Thomsen et al., "Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects", AM J CLIN N, 69(6), 1999, pp. 1135-1143
89. Schmidt, PT; Rasmussen, TN; Holst, JJ
    Tachykinins stimulate acid and pepsinogen secretion in the isolated porcine stomach
    ACTA PHYSIOLOGICA SCANDINAVICA
    
    P.T. Schmidt et al., "Tachykinins stimulate acid and pepsinogen secretion in the isolated porcine stomach", ACT PHYSL S, 166(4), 1999, pp. 335-340
90. NASLUND E; BACKMAN L; HOLST JJ; THEODORSSON E; HELLSTROM PM
    IMPORTANCE OF SMALL-BOWEL PEPTIDES FOR THE IMPROVED GLUCOSE-METABOLISM 20 YEARS AFTER JEJUNOILEAL BYPASS FOR OBESITY
    Obesity surgery
    
    E. Naslund et al., "IMPORTANCE OF SMALL-BOWEL PEPTIDES FOR THE IMPROVED GLUCOSE-METABOLISM 20 YEARS AFTER JEJUNOILEAL BYPASS FOR OBESITY", Obesity surgery, 8(3), 1998, pp. 253-260
91. WILLMS B; IDOWU K; HOLST JJ; CREUTZFELDT W; NAUCK MA
    OVERNIGHT GLP-1 NORMALIZES FASTING BUT NOT DAYTIME PLASMA-GLUCOSE LEVELS IN NIDDM PATIENTS
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    B. Willms et al., "OVERNIGHT GLP-1 NORMALIZES FASTING BUT NOT DAYTIME PLASMA-GLUCOSE LEVELS IN NIDDM PATIENTS", EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(2), 1998, pp. 103-107
92. RASMUSSEN TN; BERSANI M; SCHMIDT P; THIM L; KOFOD H; JORGENSEN PN; POULSEN SS; HOLST JJ
    ISOLATION AND MOLECULAR CHARACTERIZATION OF PORCINE CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND ITS ENDOCRINE EFFECTS IN THE PORCINE PANCREAS
    Pancreas
    
    T.N. Rasmussen et al., "ISOLATION AND MOLECULAR CHARACTERIZATION OF PORCINE CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND ITS ENDOCRINE EFFECTS IN THE PORCINE PANCREAS", Pancreas, 16(2), 1998, pp. 195-204
93. SVARTBERG J; HOLST JJ; GUTNIAK M; ADNER N
    THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    Pancreas
    
    J. Svartberg et al., "THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)", Pancreas, 16(1), 1998, pp. 66-71
94. SEIFARTH C; BERGMANN J; HOLST JJ; RITZEL R; SCHMIEGEL W; NAUCK MA
    PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS
    Diabetic medicine
    
    C. Seifarth et al., "PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS", Diabetic medicine, 15(6), 1998, pp. 485-491
95. NAUCK MA; WEBER I; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
    NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS
    Diabetic medicine
    
    M.A. Nauck et al., "NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS", Diabetic medicine, 15(11), 1998, pp. 937-945
96. Zimmermann-Belsing, T; Dreyer, M; Holst, JJ; Feldt-Rasmussen, U
    The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects
    CLINICAL ENDOCRINOLOGY
    
    T. Zimmermann-Belsing et al., "The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects", CLIN ENDOCR, 49(5), 1998, pp. 589-595
97. WETTERGREN A; WOJDEMANN M; HOLST JJ
    THE INHIBITORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE ON ANTRAL MOTILITY IS ANTAGONIZED BY ITS N-TERMINALLY TRUNCATED PRIMARY METABOLITE GLP-1 (9-36)AMIDE
    Peptides (New York, N.Y. 1980)
    
    A. Wettergren et al., "THE INHIBITORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE ON ANTRAL MOTILITY IS ANTAGONIZED BY ITS N-TERMINALLY TRUNCATED PRIMARY METABOLITE GLP-1 (9-36)AMIDE", Peptides (New York, N.Y. 1980), 19(5), 1998, pp. 877-882
98. WETTERGREN A; WOJDEMANN M; HOLST JJ
    GLUCAGON-LIKE PEPTIDE-1 INHIBITS GASTROPANCREATIC FUNCTION BY INHIBITING CENTRAL PARASYMPATHETIC OUTFLOW
    American journal of physiology: Gastrointestinal and liver physiology
    
    A. Wettergren et al., "GLUCAGON-LIKE PEPTIDE-1 INHIBITS GASTROPANCREATIC FUNCTION BY INHIBITING CENTRAL PARASYMPATHETIC OUTFLOW", American journal of physiology: Gastrointestinal and liver physiology, 38(5), 1998, pp. 984-992
99. WETTERGREN A; PRIDAL L; WOJDEMANN M; HOLST JJ
    AMIDATED AND NON-AMIDATED GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - NONPANCREATIC EFFECTS (CEPHALIC PHASE ACID-SECRETION) AND STABILITY IN PLASMA IN HUMANS
    Regulatory peptides
    
    A. Wettergren et al., "AMIDATED AND NON-AMIDATED GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - NONPANCREATIC EFFECTS (CEPHALIC PHASE ACID-SECRETION) AND STABILITY IN PLASMA IN HUMANS", Regulatory peptides, 77(1-3), 1998, pp. 83-87
100. NASLUND E; GRYBACK P; BACKMAN L; JACOBSSON H; HOLST JJ; THEODORSSON E; HELLSTROM PM
     DISTAL SMALL-BOWEL HORMONES - CORRELATION WITH FASTING ANTRODUODENAL MOTILITY AND GASTRIC-EMPTYING
     Digestive diseases and sciences
     
     E. Naslund et al., "DISTAL SMALL-BOWEL HORMONES - CORRELATION WITH FASTING ANTRODUODENAL MOTILITY AND GASTRIC-EMPTYING", Digestive diseases and sciences, 43(5), 1998, pp. 945-952